{
 "drug": "Fulvestrant Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "08/14/2026",
 "dayN": 11,
 "cat": "Oncology",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "08/14/2026",
   "update_type": "New",
   "initial_posting_date": "08/14/2026",
   "package_ndc": "63323-715-05",
   "generic_name": "Fulvestrant Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA210326"
    ],
    "brand_name": [
     "FULVESTRANT"
    ],
    "generic_name": [
     "FULVESTRANT"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-715"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR"
    ],
    "substance_name": [
     "FULVESTRANT"
    ],
    "rxcui": [
     "727762"
    ],
    "spl_id": [
     "c584c51e-3ce0-4682-a4dd-d0ac149201a8"
    ],
    "spl_set_id": [
     "fabe9bd8-ac23-4df1-a89a-223d5cd38914"
    ],
    "package_ndc": [
     "63323-715-01",
     "63323-715-05"
    ],
    "nui": [
     "N0000175582",
     "N0000000145",
     "N0000000168"
    ],
    "pharm_class_epc": [
     "Estrogen Receptor Antagonist [EPC]"
    ],
    "pharm_class_moa": [
     "Estrogen Receptor Antagonists [MoA]",
     "Selective Estrogen Receptor Modulators [MoA]"
    ],
    "unii": [
     "22X328QOC4"
    ]
   },
   "update_date": "08/14/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}